HLA-E and myeloid sarcoma: Specifically, we aimed to investigate whether HLA‐E*01:01 is linked to an increased risk of MS following the occurrence of an IM diagnosis, potentially due to the previously mentioned weaker immune control against EBV‐infected B cells [5].